MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. - Paulina

Login with Wikimedia

Login with your Wikimedia account to add/edit data Login

Missing/wrong data? Log in to edit

Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.

MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.

scientific article

Author/s

author: Robert F. H. Walter, Saskia Ting, Fabian D Mairinger

Work details

Publication date

February 10, 2015

Language

English

Copyright status

copyrighted